Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT04238624
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
- Anaplastic Thyroid Cancer
- BRAF Gene Mutation
- BRAF Mutation-Related Tumors
- Thyroid Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Dabrafenib — DRUGParticipants will receive dabrafenib 150 mg orally twice a day
- Trametinib — DRUGParticipants will receive trametinib 2 mg orally once a day
Study Details
This study is being done to see if adding the study drug, cemiplimab, to the standard therapy with dabrafenib and trametinib is an effective treatment against anaplastic thyroid cancer.
Key Dates
- Start date
- Jan 20, 2020
- Status verified
- Jul 2025
- Primary completion
- Jun 20, 2026
- Completion
- Jun 20, 2026
Study Design
- Enrollment
- 16 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: BRAF-mutant ATCParticipants will have a diagnosis of BRAF-V600E mutant Anaplastic Thyroid Cancer
Primary Outcome Measure
Overall Response Rate per RECIST 1.1 Criteria [ Time Frame: 2 years ]
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | - |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | New Jersey | 07748 | - |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | - |
| Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) | Commack | New York | 11725 | - |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | - |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | - |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | New York | 11553 | - |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center· New York, NY
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- New MRI Biomarkers in Head and Neck CancersRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- Environmental Factors and Thyroid CancerRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.PHASE1 · Recruiting · Pfizer · Fayetteville, Arkansas